← Leaderboards
Michael D Hogarty
Children'S Hosp Of Philadelphia
$2,636,429
Attributed
$2,890,364
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $902.9K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,890,364 · 3
By mechanism
R01$1,974,115 · 1
T32$507,871 · 1
R21$408,378 · 1
Top collaborators
- Gregory L Beatty1 shared
Most similar at Children'S Hosp Of Philadelphia
Same institution · by research overlap
- Kelly C Goldsmith$1,560,816
- David T. Teachey$3,927,557
Others in their field
Top investigators on “Relapse”
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Charles A Coltman · Southwest Oncology Group$124,514,512
- Mary M Horowitz · Medical College Of Wisconsin$85,160,686
- Monica M Bertagnolli · Strang Cancer Prevention Center$41,995,734
- Effie W Petersdorf · Fred Hutchinson Cancer Research Center$29,676,600
- Misty Ward Stevens · Intervexion Therapeutics, Llc$28,867,910
Research focus
RelapseApoptoticInnovationPlayResponseTumorCombined Modality TherapyDiagnosisMitochondriaPharmaceutical PreparationsResistanceResistance MechanismSignal TransductionStressCessation Of LifeClinicCancer CareCancer CellIn VivoMalignant NeoplasmsMutationNeuroblastomaAdultBiological Markers
Grant awards (8)
Cancer Center Research Training Program$507,871
T32 · FY2025 · CA · contact PI
Mechanistic biomarkers to enable Bcl2 inhibitor therapies for neuroblastoma$395,006
R01 · FY2025 · CA · contact PI
Mechanistic biomarkers to enable Bcl2 inhibitor therapies for neuroblastoma$375,256
R01 · FY2024 · CA · contact PI
Mechanistic biomarkers to enable Bcl2 inhibitor therapies for neuroblastoma$387,106
R01 · FY2023 · CA · contact PI
Mechanistic biomarkers to enable Bcl2 inhibitor therapies for neuroblastoma$393,718
R01 · FY2022 · CA · contact PI
Mechanistic biomarkers to enable Bcl2 inhibitor therapies for neuroblastoma$423,029
R01 · FY2021 · CA · contact PI
Altered mitochondria-ER signaling as a cause of chemotherapy resistance$215,064
R21 · FY2017 · CA · contact PI
Altered mitochondria-ER signaling as a cause of chemotherapy resistance$193,314
R21 · FY2016 · CA · contact PI